|
| |
MediGene aav Pages on BioPortfolio:
BioPortfolio - MediGene AG
Based on its successful research work, MediGene has so far developed five fundamental, patented platform technologies. The ITD, CVLP, AAV, HSV and
amplicon ...
http://www.bioportfolio.com/biocorporate/6855-MediGene_AG.ht...
|
BioPortfolio - MediGene AG
MediGene AG - Entry on Bioportfolio's Biocorporate Database. ... 6207453, Recombinant AAV vector-based transduction system and use of same ...
http://www.bioportfolio.com/biocorporate/26247-MediGene_AG.h...
|
BioPortfolio - MediGene Germany
BioPortfolio - MediGene Germany Medigene AG - AAV Technology Press ... This makes MediGene the first German biotech company with a drug on the US market.
...
http://www.bioportfolio.com/search/MediGene_Germany.html...
|
BioPortfolio - 82152 Martinsried Medigene AG
BioPortfolio - MediGene aav 3 Present address: Medigene AG, Lochhamer Stra s zlig e 11, D-82152 Martinsried, Germany .... Effect of small Rep DNA helicase
...
http://www.bioportfolio.com/search/82152_Martinsried_Medigen...
|
BioPortfolio - MediGene AG - Profile
Thus MediGene focuses on indications of high medical need and .... 6207453- Recombinant AAV vector-based transduction system and use of same ...
http://www.bioportfolio.com/biocorporate/26247-MediGene%2525...
|
Competitive Outlook on Non-Antibody Based Cancer Vaccines
9.1.2.5.2 Genzyme Acquires AAV vector Technology..........73 9.1.2.5.3 MediGene’ s AAV Platform..................73 9.1.2.6 Herpes Simplex Viruses......74 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_251.html...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
Technology Evaluation: Anticancer gene therapy, MediGene Susmita Hunt
MediGene's AAV technology combines a proprietary. purification system with high production efficiency. New AAV. production techniques have been developed ...
http://www.biomedcentral.com/content/pdf/cd-425171.pdf...
|
BioPortfolio - MediGene AG
Based on its successful research work, MediGene has so far developed five fundamental, patented platform technologies. The ITD, CVLP, AAV, HSV and
amplicon ...
http://www.bioportfolio.com/biocorporate/6855-MediGene_AG.ht...
|
Evotec / News & Events
MediGene applies Evotec OAIs leading technologies for the identification of .... including the ITD, CVLP, AAV and HSV technology, with product candidates in ...
http://www.evotec.com/en/news_events/news_article.aspx?news_...
|
BioPortfolio - MediGene AG
MediGene AG - Entry on Bioportfolio's Biocorporate Database. ... 6207453, Recombinant AAV vector-based transduction system and use of same ...
http://www.bioportfolio.com/biocorporate/26247-MediGene_AG.h...
|
BioReliance Corporation Announces Large Scale, Commercial ...
We feel that by working with BioReliance, MediGene will have the ... CVLP, AAV and HSV technologies, with seven product candidates in various stages of ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Cell & Gene Therapies - SMi Conference James Aird
The first talk of the second day focused on an AAV-based. gene therapy, indicated for the ... Development, MediGene AG, Germany) presented preclinical
...
http://www.biomedcentral.com/content/pdf/cd-510741.pdf...
|
Patentee Index
Hallek, Michael; Ried, Martin; Deleage, Gilbert; and Girod, Anne, to Medigene Aktiengesellschaft AAv scleroprotein, production and use thereof 07314912 Cl.
...
http://uspto.gov/web/patents/patog/week01/OG/patentee/alphaH...
|
DNA helicase-mediated packaging of adeno-associated virus type 2 ...
3 Present address: Medigene AG, Lochhamer Stra s zlig ... proteins of adeno- associated virus type 2 (AAV-2) are required to translocate capsid-associated,
...
http://www.nature.com/emboj/journal/v20/n12/abs/7593825a.htm...
|
Recombinant adeno-associated virus vectors *Michael Hallek , Anne ...
MediGene AG. Martinsried bei München. Germany. * author for correspodence ...... capacity of adeno-associated virus (AAV) and the potential ...
http://www.biomedcentral.com/content/pdf/cd-307965.pdf...
|
US 7285381 B1 Scleroprotein of an adeno-associated virus with ...
Assigned to MediGene Aktiengesellschaft, Planegg/Martinsried (Germany) ... A method for purifying AAV particles, said method comprising providing AAV ...
http://www.uspto.gov/web/patents/patog/week43/OG/html/1323-4...
|
|
